Immune checkpoint blockade therapy in head and neck cancer: a review
Head and neck cancer (HNC) is a common malignant tumor, carrying a poor prognosis, and despite advances in oncology, this rate has not improved significantly for decades. It has recently been evaluated that the immunologic checkpoint inhibitors become a novel promising strategic immunotherapy in the...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Update Dental College,
2018-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Head and neck cancer (HNC) is a common malignant tumor, carrying a poor prognosis, and despite advances in oncology, this rate has not improved significantly for decades. It has recently been evaluated that the immunologic checkpoint inhibitors become a novel promising strategic immunotherapy in the treatment of metastatic cancer. Therefore, our current review article will discuss the biological role and impact of the immune checkpoint inhibitor in HNC. Update Dent. Coll. j: 2018; 8 (2): 30-33 |
|---|---|
| Item Description: | 10.3329/updcj.v8i2.40384 2226-8715 2307-3160 |